Clinical evaluation of once-weekly dosing of epoetin alfa in chemotherapy patients: improvements in hemoglobin and quality of life are similar to three-times-weekly dosing.

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Journal of Clinical Oncology

• Publication date

  2001-06-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1200/JCO.2001.19.11.2875PMID 11387360
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Impact of epoetin alfa in chemotherapy-associated anemia.

  1998cited by this paper
• Impact of epoetin alfa in chemotherapy-associated anemia.

  1998cited by this paper
• Pharmacokinetics and pharmacodynamics of recombinant human erythropoietin after single and multiple subcutaneous doses to healthy subjects*

  1998cited by this paper
• Quality-of-life benefit in chemotherapy patients treated with epoetin alfa is independent of disease response or tumor type: results from a prospective community oncology study. Procrit Study Group.

  1998cited by this paper
• Measuring fatigue and other anemia-related symptoms with the Functional Assessment of Cancer Therapy (FACT) measurement system.

  1997cited by this paper
• Erythropoietin reduces anemia and transfusions after chemotherapy with paclitaxel and carboplatin

  1997cited by this paper
• Impact of therapy with epoetin alfa on clinical outcomes in patients with nonmyeloid malignancies during cancer chemotherapy in community oncology practice. Procrit Study Group.

  1997cited by this paper
• The Functional Assessment of Cancer Therapy-Anemia (FACT-An) Scale: a new tool for the assessment of outcomes in cancer anemia and fatigue.

  1997cited by this paper
• A safety and efficacy comparison study of two dosing regimens of epoetin alfa in patients undergoing major orthopedic surgery.

  1996cited by this paper
• 232 Clinical and health status assessments in anaemic chronic lymphocytic leukemia (CLL) patients treated with epoetin alfa

  1995cited by this paper
• Recombinant human erythropoietin for the correction of cancer associated anemia with and without concomitant cytotoxic chemotherapy

  1995cited by this paper
• Efficacy of different dosing regimens for recombinant human erythropoietin in a simulated perisurgical setting: the importance of iron availability in optimizing response.

  1994cited by this paper
• Erythropoietin for anaemia in cancer patients.

  1993cited by this paper
• Interpretation of quality of life changes

  1993cited by this paper
• Response to recombinant human erythropoietin (rHuEpo) in patients with cancer-related anaemia

  1993cited by this paper
• Treatment of chemotherapy-induced anemia with recombinant human erythropoietin in cancer patients.

  1991cited by this paper
• Recombinant Human Erythropoietin

  1989cited by this paper
• Clinical applications of visual analogue scales: a critical review

  1988cited by this paper
• Assessment of the quality of life of patients with advanced cancer.

  1983cited by this paper
• Toxicity and response criteria of the Eastern Cooperative Oncology Group

  1982cited by this paper

• Side effects of prostate cancer therapies and potential management

  2024cites this paper
• Intravenous Iron Supplementation for the Treatment of Chemotherapy-Induced Anemia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

  2022cites this paper
• Reduced Cancer-Related Fatigue after Tablet-Based Exercise Education for Patients

  2022cites this paper
• Literature Review of Fatigue Scales and Association with Clinically Meaningful Improvements in Outcomes Among Patients With and Without Paroxysmal Nocturnal Hemoglobinuria

  2022influential citation
• The addition of oral iron improves chemotherapy‐induced anemia in patients receiving erythropoiesis‐stimulating agents

  2022cites this paper
• Comparative pharmacoeconomic analysis of the use of erythropoiesis-stimulating drugs for the treatment of anemia in cancer patients

  2021cites this paper
• Perioperative Anemia Management for the Onco-Surgical Patient

  2021cites this paper
• Treatment of chemotherapy induced anemia; a randomized clinical trial to compare quality of life in patients taking intravenous versus oral iron

  2020cites this paper
• Efficacy of intravenous iron treatment for chemotherapy-induced anemia: A prospective Phase II pilot clinical trial in South Korea

  2020cites this paper
• Treatment of anemia in cancer patients undergoing chemotherapy with intravenous ferric carboxymaltose without erythropoiesis-stimulating agents

  2020cites this paper
• Iron Deficiency and Anemia in Cancer Patients: The Role of Iron Treatment in Anemic Cancer Patients

  2020cites this paper
• Recent update in the pathogenesis and treatment of chemotherapy and cancer induced anemia.

  2019cites this paper
• Effect of acupuncture at 3 anti-fatigue acupoints in the treatment of cancer-related fatigue in patients with cancer

  2019cites this paper
• Iron in the biology and treatment of gastrointestinal cancer

  2019cites this paper
• Chemotherapy-induced anemia: etiology, pathophysiology, and implications for contemporary practice

  2018cites this paper
• Feasibility of Intravenous Iron Isomaltoside to Improve Anemia and Quality of Life During Palliative Chemotherapy for Esophagogastric Adenocarcinoma

  2018cites this paper
• Transfusion practice patterns in patients with anemia receiving myelosuppressive chemotherapy for nonmyeloid cancer: results from a prospective observational study

  2018cites this paper
• Management of anaemia and iron deficiency in patients with cancer: ESMO Clinical Practice Guidelines†

  2018cites this paper
• Patterns of care in Jehovah's Witnesses patients with solid tumours and lymphoma

  2018cites this paper
• The Relationship among Chronic Disease, Feeling-for-Their-Age, Sleep Quality, Health-Related Quality of Life and Activities of Daily Living of Community-Dwelling Persons over 55 Years of Age

  2018cites this paper
• Fatigue- and health-related quality-of-life in anemic patients with lymphoma or multiple myeloma

  2018cites this paper
• Erythropoietin to Reduce Mortality in Traumatic Brain Injury: A Post-hoc Dose-effect Analysis

  2017cites this paper
• Cancer-related fatigue treatment: An overview.

  2017cites this paper
• Clinical Evolution of a Pleiotropic Cytokine

  2017cites this paper
• Yttrium-90 radioembolization treatment for unresectable hepatocellular carcinoma: a single-centre prognostic factors analysis

  2017cites this paper
• The course of cancer related fatigue up to ten years in early breast cancer patients: What impact in clinical practice?

  2017cites this paper
• Cancer, anémie et place de l'érythropoïétine Cancer, anaemia and place of erythropoietin

  2016cites this paper
• Red Blood Cell Transfusion Strategies in Adult and Pediatric Patients with Malignancy.

  2016cites this paper
• A Randomized, Open-Label, Multicenter, Phase III Study of Epoetin Alfa Versus Best Standard of Care in Anemic Patients With Metastatic Breast Cancer Receiving Standard Chemotherapy.

  2016cites this paper
• Combination with intravenous iron supplementation or doubling erythropoietin dose for patients with chemotherapy-induced anaemia inadequately responsive to initial erythropoietin treatment alone: study protocol for a randomised controlled trial

  2016cites this paper
• Review of hematological indices of cancer patients receiving combined chemotherapy & radiotherapy or receiving radiotherapy alone.

  2016cites this paper
• Efficacy and safety of darbepoetin alfa initiated at hemoglobin ≤10 g/dL in patients with stage IV cancer and chemotherapy‐induced anemia

  2016cites this paper
• A randomized comparison of once weekly epoetin alfa to extended schedule epoetin or darbepoetin in chemotherapy‐associated anemia

  2015cites this paper
• The effects of erythropoiesis-stimulating agents on the short-term and long-term survivals in metastatic breast cancer patients receiving chemotherapy: a SEER population-based study

  2015cites this paper
• Iron metabolism and iron supplementation in cancer patients

  2015cites this paper
• Epoetin beta for the treatment of chemotherapy-induced anemia: an update

  2015cites this paper
• Effects of erythropoiesis-stimulating agents on fatigue- and anaemia-related symptoms in cancer patients: systematic review and meta-analyses of published and unpublished data

  2014cites this paper
• Prospective, randomized, controlled, and open study in primarily inoperable, stage III non-small cell lung cancer (NSCLC) patients given sequential radiochemotherapy with or without epoetin alfa.

  2014cites this paper
• Dose efficiency of erythropoiesis-stimulating agents for the treatment of patients with chemotherapy-induced anemia: a systematic review.

  2014cites this paper
• Erythropoietin treatment in chemotherapy-induced anemia in previously untreated advanced esophagogastric cancer patients

  2014cites this paper
• Current management of anemia in oncology

  2014cites this paper
• [Use of erythropoiesis stimulating agents].

  2014cites this paper
• Coste-efectividad del tratamiento de la anemia inducida por quimioterapia con agentes estimuladores de la eritropoyesis

  2014influential citation
• A European patient record study on diagnosis and treatment of chemotherapy-induced anaemia

  2014cites this paper
• NCCN Guidelines Version 3.2014 Panel Members Cancer- and Chemotherapy-Induced Anemia

  2014cites this paper
• Sleep Disorders and Fatigue: Special Issues in the Older Adult With Cancer

  2014cites this paper
• Erythropoietin therapy after allogeneic hematopoietic cell transplantation: a prospective, randomized trial.

  2014cites this paper
• Erythropoietin-stimulating agents and clinical outcomes in metastatic breast cancer patients with chemotherapy-induced anemia: a closed debate?

  2014cites this paper
• The Efficacy of Recombinant Human Erythropoietin in Treatment Chemotherapy Induced Anemia in Children Diagnosed with a Solid Cancer

  2014cites this paper
• Erythropoietin promotes breast tumorigenesis through tumor-initiating cell self-renewal.

  2014cites this paper
• Final results from the prospective phase III WSG-ARA trial: impact of adjuvant darbepoetin alfa on event-free survival in early breast cancer.

  2014cites this paper
• Usefulness of the PERFORM questionnaire to measure fatigue in cancer patients with anemia: a prospective, observational study

  2013cites this paper
• Adding Epoetin Alfa to Intense Dose-Dense Adjuvant Chemotherapy for Breast Cancer: Randomized Clinical Trial

  2013cites this paper
• Adding Epoetin Alfa to Intense Dose-Dense Adjuvant Chemotherapy for Breast Cancer: Randomized Clinical Trial

  2013cites this paper
• NUTRITIONAL ASSESSMENT OF PRISONERS LIVING WITH HIV/AIDS IN SELECTED PRISONS IN TANZANIA

  2013cites this paper
• Clinical practice guidelines on cancer-related anemia (2012-2013 Edition)

  2013cites this paper
• Bone Marrow Toxicity: Red Blood Cells

  2013influential citation
• Lenalidomide in International Prognostic Scoring System Low and Intermediate-1 risk myelodysplastic syndromes with del(5q): an Italian phase II trial of health-related quality of life, safety and efficacy

  2013cites this paper
• Impacts of Black Box Warning, National Coverage Determination, and Risk Evaluation and Mitigation Strategies on the Inpatient On-Label and Off-label Use of Erythropoiesis-Stimulating Agents

  2013cites this paper
• Quality of Life and Supportive Care in Multiple Myeloma

  2013cites this paper
• Intravenous iron monotherapy for the treatment of non-iron-deficiency anemia in cancer patients undergoing chemotherapy: a pilot study

  2013cites this paper
• Treatment of low-risk myelodysplastic syndrome: hematopoietic growth factors erythropoietins and thrombopoietins.

  2012cites this paper
• Traitements de l’anémie par carence martiale en oncologie

  2012cites this paper
• Pharmacokinetics and Pharmacodynamics of Therapeutic Peptides and Proteins

  2012cites this paper
• Cancer- and chemotherapy-induced anemia.

  2012cites this paper
• Assessing the effect of darbepoetin alfa on patient-reported fatigue in chemotherapy-induced anemia in four randomized, placebo-controlled clinical trials

  2012cites this paper
• The impact of fatigue and anemia on functional status in older cancer patients treated with chemotherapy

  2012cites this paper
• Erythropoietin or darbepoetin for patients with cancer.

  2012cites this paper
• Management of Anaemia

  2012cites this paper
• The anemia impact measure (AIM): development and content validation of a patient-reported outcome measure of anemia symptoms and symptom impacts in cancer patients receiving chemotherapy

  2012cites this paper
• Addition of iron to erythropoiesis-stimulating agents in cancer patients: a meta-analysis of randomized trials

  2012cites this paper
• Cost-utility analysis of survival with epoetin-alfa versus placebo in stage IV breast cancer

  2012cites this paper
• Clinical practice guidelines on cancer-related anemia (2012-2013 Edition).

  2012cites this paper
• Guidelines and Recommendations for the Management of Anaemia in Patients with Lymphoid Malignancies

  2012influential citation
• Cancer- and chemotherapy-induced anemia.

  2012cites this paper
• Prevalence and management of cancer-related anaemia, iron deficiency and the specific role of i.v. iron.

  2012cites this paper
• The Clinical Value of Erythropoietin in Patients with Cancer

  2012influential citation
• Darbepoietin-Alfa after High-Dose Melphalan and Autologous Hemopoietic Progenitor Cell in Multiple Myeloma Patients: A Pilot Study

  2012cites this paper
• Reductions in anaemia and fatigue are associated with improvements in productivity in cancer patients receiving chemotherapy

  2012cites this paper
• Blood transfusions for anaemia in patients with advanced cancer.

  2012cites this paper
• [Iron deficiency and anemia in oncology].

  2012cites this paper
• Fatigue Related Psychosocial Problems in Cancer Patients and their Solutions

  2012cites this paper
• Darbepoetin Alfa

  2012cites this paper
• Clinical and economic impact of epoetins in cancer care

  2012cites this paper
• Tumorassoziierte Fatigue

  2011cites this paper
• Dopamine Release and Uptake in Animal Models of Neurological Diseases

  2011cites this paper
• Una valutazione economica degli agenti stimolanti l’eritropoiesi nel trattamento dell’anemia indotta da chemioterapia in Italia

  2011cites this paper
• Der Tumorsuppressor Wt1 aktiviert die Transkription des Erythropoietinrezeptors in hämatopoietischen Vorläuferzellen

  2011cites this paper
• The impact of anemia on quality of life and hospitalisation in elderly cancer patients undergoing chemotherapy.

  2011cites this paper
• IV iron sucrose for cancer and/or chemotherapy-induced anemia in patients treated with erythropoiesis-stimulating agents

  2011cites this paper
• Effectiveness of darbepoetin alfa in a cohort of oncology patients with chemotherapy-induced anaemia. Relationship between variation in three fatigue-specific quality of life questionnaire scores and change in haemoglobin level

  2011cites this paper
• Iron replacement therapy in cancer-related anemia: introduction.

  2011cites this paper
• Supportive therapy in multiple myeloma.

  2011cites this paper
• Health utilities associated with hemoglobin levels and blood loss in postmenopausal women: the Women's Health Initiative.

  2011cites this paper
• Impact of changes in reimbursement policies and institutional practice algorithm for utilization of erythropoietic-stimulating agents on treatment patterns and costs in anemic lymphoma patients

  2011cites this paper
• ERITROPOIETINA: PRODUÇÃO RENAL, ANEMIA E CANCRO

  2011cites this paper
• Cytokines in MDS: Abnormalities and Treatment

  2011cites this paper
• Iron replacement therapy in cancer-related anemia.

  2011cites this paper
• Clinical benefits of two different dosing schedules of recombinant human erythropoietin in anemic patients with advanced head and neck cancer.

  2010cites this paper
• Use of latent growth curve models for assessing the effects of darbepoetin alfa on hemoglobin and fatigue.

  2010cites this paper